Efficacy of Anamorelin, a novel non-peptide ghrelin analogue, in patients with advanced non-small cell lung cancer (NSCLC) and Cachexia—Review and expert opinion
David C. Currow, Matthew Maddocks, David Cella, Maurizio Muscaritoli
Research output: Contribution to journal › Review article › peer-review
24Citations
(Scopus)
23Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Efficacy of Anamorelin, a novel non-peptide ghrelin analogue, in patients with advanced non-small cell lung cancer (NSCLC) and Cachexia—Review and expert opinion'. Together they form a unique fingerprint.